Актуальные вопросы интерферонотерапии
- Авторы: Блохин Б.М.1, Прохорова А.Д.1, Суюндукова А.С.1
-
Учреждения:
- ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н И. Пирогова» Минздрава России
- Выпуск: № 7-8 (2018)
- Страницы: 125-132
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2412-4036/article/view/288177
- ID: 288177
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Ключевые слова
Полный текст
Об авторах
Борис Моисеевич Блохин
ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н И. Пирогова» Минздрава России
Email: blokhinb@gmail.com
д.м.н., проф., зав. кафедрой поликлинической и неотложной педиатрии педиатрического факультета
Анастасия Дмитриевна Прохорова
ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н И. Пирогова» Минздрава России
Email: prohorovaa525@gmail.com
ассистент кафедры поликлинической и неотложной педиатрии педиатрического факультета
Алия Сагитовна Суюндукова
ФГБОУ ВО «Российский национальный исследовательский медицинский университет им. Н И. Пирогова» Минздрава России
Email: a.s.suyundukova@hotmail.com
к.м.н., доцент кафедры поликлинической и неотложной педиатрии педиатрического факультета
Список литературы
- Samuel C.E. Antiviral actions of interferons. Clin Microbiol Rev. 2001 Oct; 14(4): 778-809, table of contents.
- Bandurska K., Krol I., Myga-Nowak M. Interferons: between structure and function. Postepy Hig Med Dosw (Online). 2014 May 6; 68: 428-40.
- Ершов Ф.И., Наровлянский А.Н. Основные итоги изучения системы интерферона к 2011 году. В сборнике Интерферон-2011. Под ред. акад. РАМН, проф. Ф.И. Ершова и проф. А.Н. Наровлянского. Москва, 2012. С. 14-34.
- Park S.H., Kang K., Giannopoulou E. et al. Type I interferons and the cytokine TNF cooperatively reprogram the macrophage epigenome to promote inflammatory activation. Nat Immunol. 2017 Oct; 18(10): 1104-16.
- Lachova V., Skorvanova L., Svetlikova D. et al. Comparison of transcriptional profiles of interferons, CXCL10 and RIG-1 in influenza infected A549 cells stimulated with exogenous interferons. Acta Virol. 2017; 61(2): 183-90.
- Малиновская В.В. Онтогенез системы интерферона и проблемы терапии в неонатальном периоде. В сборнике Интерферон-2011. Под ред. акад. РАМН, проф. Ф.И. Ершова и проф. А.Н. Наровлянского. Москва, 2012. С. 35-51.
- Sheng Y.J., Xu S.S., Li X.J. et al. Low birth weight contributed to increased serum IL-6 levels in infantile respiratory syncytial virus infection. BMC Pediatr. 2017 Dec 16; 17(1): 205.
- Frémond M.L., Uggenti C., Van Eyck L. et al. Brief Report: Blockade of TANK-Binding Kinase 1/IKK Inhibits Mutant Stimulator of Interferon Genes (STING)-Mediated Inflammatory Responses in Human Peripheral Blood Mononuclear Cells. Arthritis Rheumatol. 2017 Jul; 69(7): 1495-501.
- Maughan A. Ogbuagu. Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection. O.Expert Opin Drug Metab Toxicol. 2018 Feb; 14(2): 219-27.
- Herrington-Symes A., Choi J.W., Brocchini S. Interferon dimers: IFN-PEG-IFN. J Drug Target. 2017 Nov - Dec; 25(9-10): 881-90.
- Ершов Ф.И., Шульдяков А.А., Романцов М.Г., Ляпина Е.П., Соболева Л.А. Результаты и перспективы использования индукторов интерферона в лечении инфекционных болезней. Вестник Российской академии медицинских наук. 2013; 10: 46-52.
- Zhang K.J., Yin X.F., Yang Y.Q. et al. A Potent In Vivo Antitumor Efficacy of Novel Recombinant Type I Interferon. Clin Cancer Res. 2017 Apr 15; 23(8): 2038-49
- Rizza P., Moretti F., Capone I., Belardelli F. Role of type I interferon in inducing a protective immune response: perspectives for clinical applications. Cytokine Growth Factor Rev. 2015 Apr; 26(2): 195-201.
- Мухачева М.В., Бейн Б.Н. Роль интерферонов в иммунитете у больных с церебральными опухолями. Фундаментальные исследования. 2015; 1-7: 1486-1490.
- Симоненко В.Б., Дулин П.А., Маканин М.А. Возможности таргетной терапии нейроэндокринных опухолей. Клиническая медицина. 2014; 92(8): 5-14.
- Глазкова Н.Н. Иммуномодуляторы в лечении рака. Вестник Калужского университета. 2016; 2: 18-28.
- Tong R., Feng L, Zhang L. et al. Decreased Interferon Alpha/Beta Signature Associated with Human Lung Tumorigenesis. J Interferon Cytokine Res. 2015 Dec; 35(12): 963-68.
- Buoncervello M., Romagnoli G., Buccarelli M. et al. IFN-a potentiates the direct and immune-mediated antitumor effects of epigenetic drugs on both metastatic and stem cells of colorectal cancer. Oncotarget. 2016 May 3; 7(18): 26361-73. doi: 10.18632/oncotarget.8379.
- Liu X., Lu J., He M.L. et al. Antitumor effects of interferon-alpha on cell growth and metastasis in human nasopharyngeal carcinoma. Curr Cancer Drug Targets. 2012 Jun; 12(5): 561-70.
- 2Yin H., Chen N., Guo R. et al. Antitumor potential of a synthetic interferon-alpha/PLGF-2 positive charge peptide hybrid molecule in pancreatic cancer cells. Sci Rep. 2015 Nov 20; 5: 16975.
- Skov V., Riley C.H., Thomassen et al. The impact of interferon-alpha2 on HLA genes in patients with polycythemia vera and related neoplasms./ M,Leuk Lymphoma. 2017 Aug; 58(8): 1914-21.
- Santak G., Santak M., Forcic D. Comparison of antitumor effects of native and recombinant human interferon-a on non-small cell lung cancer cells. Anticancer Res. 2013 May; 33(5): 2043-46.
- Абатуров А.Е., Юлиш Е.И. Роль интерферонов в защите респираторного тракта. Часть 2. Механизмы действия интерферонов. Здоровье ребенка. 2007; 6: 136-144.
- Ghodke-Puranik Y., Dorschner J.M., Vsetecka D.M. et al. Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells. Arthritis Rheumatol. 2017 Dec; 69(12): 2328-37.
- Imran M., Waheed Y., Manzoor S. et al. Interaction of Hepatitis C virus proteins with pattern recognition receptors. Virol J. 2012 Jun 22; 9: 126.
- Rönnblom L. The importance of the type I interferon system in autoimmunity. Clin Exp Rheumatol. 2016 Jul-Aug; 34(4 Suppl 98): 21-4.
- Torigoe M., Iwata S., Nakayamada S. et al. Metabolic Reprogramming Commits Differentiation of Human CD27+IgD+ B Cells to Plasmablasts or CD27-IgD- Cells. J Immunol. 2017 Jul 15; 199(2): 425-34.
- Jin Z., Fan J, Zhang Y. et al. Comparison of morphology, phenotypes and function between cultured human IL-4-DC and IFN-DC. Mol Med Rep. 2017 Nov; 16(5): 7345-54.
- Murayama G., Furusawa N., Chiba A. et al. Enhanced IFN-a production is associated with increased TLR7 retention in the lysosomes of palasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Res Ther. 2017 Oct 19; 19(1): 234.
- Imgenberg-Kreuz J., Sandling J.K., Björk A. et al. Transcription profiling of peripheral B cells in antibody-positive primary Sjögren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature. Scand J Immunol. 2018 May; 87(5): e12662.
- Ghodke-Puranik Y., Dorschner J.M., Vsetecka D.M. et al. Lupus-Associated Functional Polymorphism in PNP Causes Cell Cycle Abnormalities and Interferon Pathway Activation in Human Immune Cells. Arthritis Rheumatol. 2017 Dec; 69(12): 2328-37.
- Sossau D., Kofler L., Eigentler T. Type 1 diabetes mellitus caused by treatment with low-dose interferon-a in a melanoma patient. Melanoma Res. 2017 Oct; 27(5): 516-18.
- Lombardi A., Tsomos E., Hammerstad S.S., Tomer Y. Interferon alpha: The key trigger of type 1 diabetes. J Autoimmun. 2018 Aug 14. pii: S0896-8411(18)30323-8.
- Khan W.A., Qureshi J.A. Increased binding of circulating systemic lupus erythematosus autoantibodies to recombinant interferon alpha 2b. APMIS. 2015 Dec; 123(12): 1016-24.
- Heim M.H. Innate immunity and HCV. J Hepatol. 2013 Mar; 58(3): 564-74.
- Haldipur B., Bhukya P.L., Arankalle V., Lole K. Positive Regulation of Hepatitis E Virus Replication by MicroRNA-122. J Virol. 2018 May 14; 92(11). pii: e01999-17.
- Davidson S., McCabe T.M., Crotta S. et al. IFNÀ is a potent anti-influenza therapeutic without the inflammatory side effects of IFNa treatment. EMBO Mol Med. 2016 Sep 1; 8(9): 1099-112.
- Como C.N., Pearce C.M., Cohrs R.J., Baird N.L. Interleukin-6 and type 1 interferons inhibit varicella zoster virus replication in human neurons. Virology. 2018 Sep; 522: 13-8.
- Tang L.S.Y., Covert E., Wilson E., Kottilil S. Chronic Hepatitis B Infection: A Review. JAMA. 2018 May 1; 319(17): 1802-13.
- Friedman A., Siewe N. Chronic hepatitis B virus and liver fibrosis: A mathematical model. PLoS One. 2018 Apr 10; 13(4): e0195037.
- Maughan A., Ogbuagu O. Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection. Expert Opin Drug Metab Toxicol. 2018 Feb; 14(2): 219-27.
- Hayden F.G., de Jong M.D. Emerging influenza antiviral resistance threats. J Infect Dis. 2011 Jan 1; 203(1): 6-10.
- Betakova T., Kostrabova A., Lachova V., Turianova L. Cytokines Induced During Influenza Virus Infection. Curr Pharm Des. 2017; 23(18): 2616-22.
- Lee S., Hirohama M., Noguchi M. et al. Influenza A Virus Infection Triggers Pyroptosis and Apoptosis of Respiratory Epithelial Cells through the Type I Interferon Signaling Pathway in a Mutually Exclusive Manner. J Virol. 2018 Jun 29; 92(14). pii: e00396-18.
- Shepardson K.M., Larson K., Morton R.V. et al. Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection. MBio. 2016 May 3; 7(3). pii: e00506-16.
- Rynda-Apple A., Robinson K.M., Alcorn J.F. Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of Disease. Infect Immun. 2015 Oct; 83(10): 3764-70.
- Robinson K.M., Kolls J.K., Alcorn J.F. The immunology of influenza virus-associated bacterial pneumonia. Curr Opin Immunol. 2015 Jun; 34: 59-67.
- Rynda-Apple A., Harmsen A., Erickson A.S. et al. Regulation of IFN-y by IL-13 dictates susceptibility to secondary postinfluenza MRSA pneumonia. Eur J Immunol. 2014 Nov; 44(11): 3263-72.
- Carolan L.A., Rockman S., Borg K. et al. Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B Viruses. J Virol. 2015 Dec 30; 90(6): 2838-48.
- Sobrevilla-Navarro A.A., Sandoval-Rodriguez A., Garcia-Banuelos J.J. et al. Interferon-a Silencing by Small Interference RNA Increases Adenovirus Transduction and Transgene Expression in Huh7 Cells. Mol Biotechnol. 2018 Apr; 60(4): 251-58.
- Xia C., Wolf J.J., Vijayan M. et al. Casein Kinase 1a Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus. J Virol. 2018 Mar 14; 92(7). pii: e00006-18.
- Jiang H., Shen S.M., Yin J. et al. Influenza virus non-structural protein 1 inhibits the production of interferon β of alveolar epithelial cells upon the infection of influenza A H1N1. Mol Med Rep. 2017 Oct; 16(4): 4553-60.
- Song J., Hu Y., Li J. et al. Suppression of the toll-like receptor 7-dependent type I interferon production pathway by autophagy resulting from enterovirus 71 and coxsackievirus A16 infections facilitates their replication. Arch Virol. 2018 Jan; 163(1): 135-44.
- Akiyama H., Ramirez N.P., Gibson G. et al. Interferon-Inducible CD169/Siglec1 Attenuates Anti-HIV-1 Effects of Alpha Interferon. Gummuluru S4.J Virol. 2017 Oct 13; 91(21). pii: e00972-17.
- Narulla M.S., Alasiri A., Charmier L. et al. Positive and Negative Regulation of Type I Interferons by the Human T Cell Leukemia Virus Antisense Protein HBZ. J Virol. 2017 Sep 27; 91(20). pii: e00853-17.
- Canepa C., Imperiale J.C., Berini C.A. et al. Development of a Drug Delivery System Based on Chitosan Nanoparticles for Oral Administration of Interferon-a. Biomacromolecules. 2017 Oct 9; 18(10): 3302-09.
- Elbaz T., Elserafy M., Elakel W. et al. Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience. J Interferon Cytokine Res. 2017 Aug; 37(8): 348-53.
- Weber E., Reynaud Q., Fort R. et al. Immunomodulatory treatments for persistent and chronic immune thrombocytopenic purpura: A PRISMA-compliant systematic review and meta-analysis of 28 studies. Medicine (Baltimore). 2017 Sep; 96(37): e7534.
- Ragusa R., Bertino G., Bruno A. et al. Evaluation of health status in patients with hepatitis c treated with and without interferon. Health Qual Life Outcomes. 2018 Jan 17; 16(1):17.
- Botonczyk Ł., Siekierska-Hellmann M., Wisniewski P. et al. Epidemiology, risk factors and prognosis of Interferon alpha induced thyroid disorders. A Prospective Clinical Study. Postepy Hig Med Dosw (Online). 2017 Sep 25; 71(0): 842-49.
- Sayiner Z.A., Eraydin A., Metin T., Özkaya M. Interferon alpha-induced non-immune thyrotoxicosis treated by plasmapheresis./ BMJ Case Rep. 2017 Sep 25; 2017. pii: bcr-2017-221228.
- Jain V., Patel R.K., Kapadia Z. et al. Drugs and hyperglycemia: A practical guide. Maturitas. 2017 Oct; 104: 80-3.
- Silva J.L., Faria D.S., Teixeira F., Afonso M.C., Peixoto D. Systemic sclerosis induced by interferon-alfa treatment of melanoma. Acta Reumatol Port. 2017 Jul-Sep; 42(3): 263-64.
- Mendieta K.L., Irfan M., Fernandez Faith E. Interferon-alpha induced psoriasis in a teenager. Pediatr Dermatol. 2018 Mar; 35(2): e136-e137.
- Fortuna G., Aria M., Schiavo J.H. Drug-induced oral lichenoid reactions: a real clinical entity? A systematic review. Eur J Clin Pharmacol. 2017 Dec; 73(12): 1523-37. doi: 10.1007/s00228-017-2325-0.
- Lee G.A., Hess L., Glasson W.J., Whitehead K. Topical Interferon Alpha-2b Induced Reactive Lymphoid Hyperplasia Masquerading as Orbital Extension of Ocular Surface Squamous Neoplasia. Cornea. 2018 Jun; 37(6): 796-98.
- Khan Faisal A.W., Nisar S., Ali S.A., Ahmad F. Effects Of Interferon Therapy On Heart. J Ayub Med Coll Abbottabad. 2016 Apr-Jun; 28(2): 276-80.
- Cubas-Gaona L.L., Diaz-Beneitez E., Ciscar M. et al. Exacerbated Apoptosis of Cells Infected with Infectious Bursal Disease Virus upon Exposure to Interferon Alpha. J Virol. 2018 May 14; 92(11). pii: e00364-18.